Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.
Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.
3BrB-PP1 is a bumped kinase inhibitor (BKI) that acts as a selective, ATP-competitive inhibitor of kinases with gatekeeper mutations.1 It increases the activity of the T. gondii bradyzoite-specific BAG1 promoter. 3BrB-PP1 has been used to study kinase activity using kinases containing mutations at gatekeeper residues in the ATP-binding pocket, thereby allowing 3BrB-PP1 to selectively inhibit the kinase.2,3
WARNING This product is not for human or veterinary use.
1. Microplate assay for screening Toxoplasma gondii bradyzoite differentiation with DUAL luciferase assay. Anal. Biochem. 464, 9-11 (2014).
2. Remodeling of the fission yeast Cdc42 cell-
3. Fission yeast NDR/LATS kinase Orb6 regulates exocytosis via phosphorylation of the exocyst complex. Cell Rep. 26(6), 1654-1667 (2019).